Chinese General Practice ›› 2023, Vol. 26 ›› Issue (16): 2013-2019.DOI: 10.12114/j.issn.1007-9572.2023.0009
Special Issue: 内分泌代谢性疾病最新文章合集
• Original Research·Focus on Population Health • Previous Articles Next Articles
Received:
2023-01-16
Revised:
2023-03-15
Published:
2023-06-05
Online:
2023-03-23
Contact:
ZHOU Shangcheng
通讯作者:
周尚成
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0009
年份(年) | 粗发病率 | 标化发病率 | 粗死亡率 | 标化死亡率 |
---|---|---|---|---|
1990 | 162.73 | 176.23 | 5.92 | 9.20 |
1991 | 169.77 | 182.00 | 5.88 | 9.02 |
1992 | 176.18 | 186.99 | 5.94 | 8.99 |
1993 | 181.88 | 191.06 | 6.04 | 9.02 |
1994 | 186.99 | 194.02 | 6.11 | 8.98 |
1995 | 190.85 | 195.78 | 6.21 | 8.98 |
1996 | 193.58 | 196.11 | 6.43 | 9.13 |
1997 | 195.10 | 195.36 | 6.63 | 9.23 |
1998 | 196.23 | 194.19 | 6.91 | 9.42 |
1999 | 197.92 | 193.29 | 7.28 | 9.71 |
2000 | 200.84 | 193.33 | 7.63 | 9.95 |
2001 | 207.64 | 196.58 | 7.99 | 10.20 |
2002 | 218.63 | 203.40 | 8.46 | 10.54 |
2003 | 231.56 | 211.57 | 8.86 | 10.74 |
2004 | 244.00 | 218.85 | 9.32 | 11.03 |
2005 | 253.23 | 222.99 | 9.59 | 11.10 |
2006 | 258.50 | 223.54 | 9.28 | 10.45 |
2007 | 261.56 | 222.25 | 9.16 | 10.04 |
2008 | 263.44 | 220.16 | 9.24 | 9.88 |
2009 | 265.25 | 218.38 | 9.43 | 9.85 |
2010 | 268.30 | 217.96 | 9.68 | 9.88 |
2011 | 272.83 | 219.18 | 9.85 | 9.79 |
2012 | 277.65 | 221.18 | 9.96 | 9.62 |
2013 | 281.99 | 223.27 | 10.15 | 9.54 |
2014 | 285.17 | 224.81 | 10.46 | 9.53 |
2015 | 286.32 | 225.11 | 10.69 | 9.45 |
2016 | 273.35 | 216.22 | 11.10 | 9.52 |
2017 | 259.74 | 206.90 | 11.43 | 9.51 |
2018 | 260.08 | 205.03 | 11.76 | 9.46 |
2019 | 265.45 | 204.31 | 12.16 | 9.44 |
Table 1 Diabetes incidence and deaths in China,1990—2019
年份(年) | 粗发病率 | 标化发病率 | 粗死亡率 | 标化死亡率 |
---|---|---|---|---|
1990 | 162.73 | 176.23 | 5.92 | 9.20 |
1991 | 169.77 | 182.00 | 5.88 | 9.02 |
1992 | 176.18 | 186.99 | 5.94 | 8.99 |
1993 | 181.88 | 191.06 | 6.04 | 9.02 |
1994 | 186.99 | 194.02 | 6.11 | 8.98 |
1995 | 190.85 | 195.78 | 6.21 | 8.98 |
1996 | 193.58 | 196.11 | 6.43 | 9.13 |
1997 | 195.10 | 195.36 | 6.63 | 9.23 |
1998 | 196.23 | 194.19 | 6.91 | 9.42 |
1999 | 197.92 | 193.29 | 7.28 | 9.71 |
2000 | 200.84 | 193.33 | 7.63 | 9.95 |
2001 | 207.64 | 196.58 | 7.99 | 10.20 |
2002 | 218.63 | 203.40 | 8.46 | 10.54 |
2003 | 231.56 | 211.57 | 8.86 | 10.74 |
2004 | 244.00 | 218.85 | 9.32 | 11.03 |
2005 | 253.23 | 222.99 | 9.59 | 11.10 |
2006 | 258.50 | 223.54 | 9.28 | 10.45 |
2007 | 261.56 | 222.25 | 9.16 | 10.04 |
2008 | 263.44 | 220.16 | 9.24 | 9.88 |
2009 | 265.25 | 218.38 | 9.43 | 9.85 |
2010 | 268.30 | 217.96 | 9.68 | 9.88 |
2011 | 272.83 | 219.18 | 9.85 | 9.79 |
2012 | 277.65 | 221.18 | 9.96 | 9.62 |
2013 | 281.99 | 223.27 | 10.15 | 9.54 |
2014 | 285.17 | 224.81 | 10.46 | 9.53 |
2015 | 286.32 | 225.11 | 10.69 | 9.45 |
2016 | 273.35 | 216.22 | 11.10 | 9.52 |
2017 | 259.74 | 206.90 | 11.43 | 9.51 |
2018 | 260.08 | 205.03 | 11.76 | 9.46 |
2019 | 265.45 | 204.31 | 12.16 | 9.44 |
年份(年) | 男 | 女 | 总计 | ||||||
---|---|---|---|---|---|---|---|---|---|
YLL率 | YLD率 | DALY率 | YLL率 | YLD率 | DALY率 | YLL率 | YLD率 | DALY率 | |
1990 | 182.77 | 265.20 | 447.97 | 228.56 | 255.81 | 484.38 | 204.71 | 260.74 | 465.46 |
1991 | 179.78 | 275.92 | 455.70 | 222.13 | 259.88 | 482.01 | 199.92 | 267.96 | 467.88 |
1992 | 179.13 | 285.06 | 464.19 | 219.79 | 263.12 | 482.91 | 198.31 | 274.00 | 472.31 |
1993 | 178.69 | 292.33 | 471.01 | 219.58 | 265.57 | 485.14 | 197.93 | 278.72 | 476.65 |
1994 | 178.56 | 297.46 | 476.02 | 218.20 | 267.06 | 485.25 | 197.04 | 281.92 | 478.97 |
1995 | 180.71 | 300.12 | 480.83 | 215.85 | 267.47 | 483.32 | 196.87 | 283.38 | 480.25 |
1996 | 183.84 | 299.57 | 483.42 | 216.65 | 266.20 | 482.85 | 198.82 | 282.38 | 481.21 |
1997 | 186.54 | 296.47 | 483.01 | 216.63 | 263.32 | 479.95 | 200.05 | 279.27 | 479.33 |
1998 | 190.72 | 292.54 | 483.27 | 219.62 | 259.99 | 479.61 | 203.58 | 275.51 | 479.09 |
1999 | 195.69 | 289.45 | 485.14 | 224.42 | 257.34 | 481.75 | 208.45 | 272.53 | 480.98 |
2000 | 200.16 | 288.95 | 489.11 | 226.81 | 256.50 | 483.31 | 211.98 | 271.82 | 483.80 |
2001 | 203.66 | 296.40 | 500.06 | 229.60 | 263.27 | 492.87 | 215.13 | 278.98 | 494.12 |
2002 | 209.42 | 312.42 | 521.84 | 235.17 | 278.78 | 513.95 | 220.75 | 294.90 | 515.66 |
2003 | 211.55 | 331.50 | 543.05 | 238.95 | 297.48 | 536.43 | 223.71 | 313.98 | 537.69 |
2004 | 217.71 | 348.39 | 566.10 | 241.54 | 313.53 | 555.08 | 227.93 | 330.62 | 558.55 |
2005 | 219.76 | 357.70 | 577.46 | 238.63 | 321.32 | 559.95 | 227.37 | 339.25 | 566.62 |
2006 | 207.44 | 359.47 | 566.91 | 222.84 | 321.45 | 544.29 | 213.40 | 340.24 | 553.64 |
2007 | 200.61 | 358.33 | 558.94 | 210.38 | 319.23 | 529.61 | 203.71 | 338.59 | 542.29 |
2008 | 199.44 | 355.74 | 555.18 | 201.69 | 315.82 | 517.50 | 198.68 | 335.61 | 534.30 |
2009 | 199.38 | 353.02 | 552.40 | 195.52 | 312.11 | 507.62 | 195.41 | 332.42 | 527.83 |
2010 | 200.69 | 351.70 | 552.39 | 190.74 | 309.27 | 500.02 | 193.56 | 330.37 | 523.93 |
2011 | 199.10 | 352.76 | 551.86 | 185.51 | 307.14 | 492.65 | 190.01 | 329.82 | 519.84 |
2012 | 199.24 | 355.46 | 554.69 | 177.55 | 304.90 | 482.46 | 185.71 | 330.02 | 515.73 |
2013 | 198.18 | 358.49 | 556.66 | 172.74 | 302.53 | 475.26 | 182.63 | 330.30 | 512.94 |
2014 | 198.23 | 360.64 | 558.88 | 169.93 | 299.85 | 469.77 | 181.34 | 330.00 | 511.34 |
2015 | 198.05 | 360.72 | 558.77 | 166.28 | 296.82 | 463.10 | 179.36 | 328.51 | 507.87 |
2016 | 199.38 | 350.30 | 549.68 | 166.12 | 288.55 | 454.67 | 179.95 | 319.23 | 499.18 |
2017 | 198.41 | 337.89 | 536.30 | 165.60 | 279.67 | 445.27 | 179.49 | 308.65 | 488.14 |
2018 | 197.54 | 337.67 | 535.21 | 164.86 | 280.27 | 445.12 | 178.92 | 308.81 | 487.73 |
2019 | 197.55 | 344.86 | 542.41 | 163.86 | 288.17 | 452.02 | 178.45 | 316.30 | 494.76 |
Table 2 Burden of diabetes in China,1990—2019
年份(年) | 男 | 女 | 总计 | ||||||
---|---|---|---|---|---|---|---|---|---|
YLL率 | YLD率 | DALY率 | YLL率 | YLD率 | DALY率 | YLL率 | YLD率 | DALY率 | |
1990 | 182.77 | 265.20 | 447.97 | 228.56 | 255.81 | 484.38 | 204.71 | 260.74 | 465.46 |
1991 | 179.78 | 275.92 | 455.70 | 222.13 | 259.88 | 482.01 | 199.92 | 267.96 | 467.88 |
1992 | 179.13 | 285.06 | 464.19 | 219.79 | 263.12 | 482.91 | 198.31 | 274.00 | 472.31 |
1993 | 178.69 | 292.33 | 471.01 | 219.58 | 265.57 | 485.14 | 197.93 | 278.72 | 476.65 |
1994 | 178.56 | 297.46 | 476.02 | 218.20 | 267.06 | 485.25 | 197.04 | 281.92 | 478.97 |
1995 | 180.71 | 300.12 | 480.83 | 215.85 | 267.47 | 483.32 | 196.87 | 283.38 | 480.25 |
1996 | 183.84 | 299.57 | 483.42 | 216.65 | 266.20 | 482.85 | 198.82 | 282.38 | 481.21 |
1997 | 186.54 | 296.47 | 483.01 | 216.63 | 263.32 | 479.95 | 200.05 | 279.27 | 479.33 |
1998 | 190.72 | 292.54 | 483.27 | 219.62 | 259.99 | 479.61 | 203.58 | 275.51 | 479.09 |
1999 | 195.69 | 289.45 | 485.14 | 224.42 | 257.34 | 481.75 | 208.45 | 272.53 | 480.98 |
2000 | 200.16 | 288.95 | 489.11 | 226.81 | 256.50 | 483.31 | 211.98 | 271.82 | 483.80 |
2001 | 203.66 | 296.40 | 500.06 | 229.60 | 263.27 | 492.87 | 215.13 | 278.98 | 494.12 |
2002 | 209.42 | 312.42 | 521.84 | 235.17 | 278.78 | 513.95 | 220.75 | 294.90 | 515.66 |
2003 | 211.55 | 331.50 | 543.05 | 238.95 | 297.48 | 536.43 | 223.71 | 313.98 | 537.69 |
2004 | 217.71 | 348.39 | 566.10 | 241.54 | 313.53 | 555.08 | 227.93 | 330.62 | 558.55 |
2005 | 219.76 | 357.70 | 577.46 | 238.63 | 321.32 | 559.95 | 227.37 | 339.25 | 566.62 |
2006 | 207.44 | 359.47 | 566.91 | 222.84 | 321.45 | 544.29 | 213.40 | 340.24 | 553.64 |
2007 | 200.61 | 358.33 | 558.94 | 210.38 | 319.23 | 529.61 | 203.71 | 338.59 | 542.29 |
2008 | 199.44 | 355.74 | 555.18 | 201.69 | 315.82 | 517.50 | 198.68 | 335.61 | 534.30 |
2009 | 199.38 | 353.02 | 552.40 | 195.52 | 312.11 | 507.62 | 195.41 | 332.42 | 527.83 |
2010 | 200.69 | 351.70 | 552.39 | 190.74 | 309.27 | 500.02 | 193.56 | 330.37 | 523.93 |
2011 | 199.10 | 352.76 | 551.86 | 185.51 | 307.14 | 492.65 | 190.01 | 329.82 | 519.84 |
2012 | 199.24 | 355.46 | 554.69 | 177.55 | 304.90 | 482.46 | 185.71 | 330.02 | 515.73 |
2013 | 198.18 | 358.49 | 556.66 | 172.74 | 302.53 | 475.26 | 182.63 | 330.30 | 512.94 |
2014 | 198.23 | 360.64 | 558.88 | 169.93 | 299.85 | 469.77 | 181.34 | 330.00 | 511.34 |
2015 | 198.05 | 360.72 | 558.77 | 166.28 | 296.82 | 463.10 | 179.36 | 328.51 | 507.87 |
2016 | 199.38 | 350.30 | 549.68 | 166.12 | 288.55 | 454.67 | 179.95 | 319.23 | 499.18 |
2017 | 198.41 | 337.89 | 536.30 | 165.60 | 279.67 | 445.27 | 179.49 | 308.65 | 488.14 |
2018 | 197.54 | 337.67 | 535.21 | 164.86 | 280.27 | 445.12 | 178.92 | 308.81 | 487.73 |
2019 | 197.55 | 344.86 | 542.41 | 163.86 | 288.17 | 452.02 | 178.45 | 316.30 | 494.76 |
年份(年) | 1型糖尿病 | 2型糖尿病 | ||||
---|---|---|---|---|---|---|
标化发病率 | 标化死亡率 | DALY率 | 标化发病率 | 标化死亡率 | DALY率 | |
1990 | 1.96 | 0.57 | 29.65 | 174.27 | 8.63 | 435.81 |
1991 | 1.95 | 0.55 | 28.93 | 180.05 | 8.47 | 438.95 |
1992 | 1.94 | 0.55 | 28.70 | 185.05 | 8.44 | 443.61 |
1993 | 1.94 | 0.54 | 28.41 | 189.12 | 8.48 | 448.24 |
1994 | 1.94 | 0.55 | 28.94 | 192.08 | 8.43 | 450.03 |
1995 | 1.94 | 0.55 | 29.39 | 193.84 | 8.43 | 450.86 |
1996 | 1.95 | 0.55 | 29.27 | 194.16 | 8.57 | 451.94 |
1997 | 1.98 | 0.55 | 29.02 | 193.38 | 8.68 | 450.31 |
1998 | 2.01 | 0.56 | 29.48 | 192.18 | 8.86 | 449.61 |
1999 | 2.05 | 0.56 | 29.57 | 191.24 | 9.15 | 451.41 |
2000 | 2.09 | 0.56 | 29.15 | 191.24 | 9.40 | 454.66 |
2001 | 2.13 | 0.54 | 28.31 | 194.45 | 9.66 | 465.81 |
2002 | 2.19 | 0.52 | 27.05 | 201.21 | 10.02 | 488.61 |
2003 | 2.27 | 0.49 | 25.77 | 209.30 | 10.25 | 511.92 |
2004 | 2.34 | 0.47 | 25.13 | 216.51 | 10.55 | 533.42 |
2005 | 2.42 | 0.45 | 24.09 | 220.58 | 10.65 | 542.53 |
2006 | 2.49 | 0.42 | 22.96 | 221.05 | 10.04 | 530.68 |
2007 | 2.58 | 0.39 | 22.06 | 219.67 | 9.65 | 520.24 |
2008 | 2.67 | 0.37 | 21.54 | 217.49 | 9.51 | 512.75 |
2009 | 2.74 | 0.36 | 21.05 | 215.64 | 9.49 | 506.78 |
2010 | 2.78 | 0.34 | 20.46 | 215.17 | 9.54 | 503.47 |
2011 | 2.80 | 0.33 | 19.65 | 216.38 | 9.47 | 500.18 |
2012 | 2.80 | 0.31 | 18.78 | 218.38 | 9.31 | 496.96 |
2013 | 2.80 | 0.29 | 18.23 | 220.47 | 9.24 | 494.70 |
2014 | 2.79 | 0.29 | 17.89 | 222.01 | 9.24 | 493.45 |
2015 | 2.81 | 0.28 | 17.49 | 222.30 | 9.17 | 490.38 |
2016 | 2.84 | 0.27 | 17.39 | 213.38 | 9.25 | 481.78 |
2017 | 2.90 | 0.27 | 17.36 | 204.01 | 9.24 | 470.78 |
2018 | 3.03 | 0.27 | 17.68 | 202.00 | 9.19 | 470.05 |
2019 | 3.26 | 0.27 | 18.24 | 201.06 | 9.17 | 476.52 |
Table 3 Burden of type 1 and type 2 diabetes in China,1990—2019
年份(年) | 1型糖尿病 | 2型糖尿病 | ||||
---|---|---|---|---|---|---|
标化发病率 | 标化死亡率 | DALY率 | 标化发病率 | 标化死亡率 | DALY率 | |
1990 | 1.96 | 0.57 | 29.65 | 174.27 | 8.63 | 435.81 |
1991 | 1.95 | 0.55 | 28.93 | 180.05 | 8.47 | 438.95 |
1992 | 1.94 | 0.55 | 28.70 | 185.05 | 8.44 | 443.61 |
1993 | 1.94 | 0.54 | 28.41 | 189.12 | 8.48 | 448.24 |
1994 | 1.94 | 0.55 | 28.94 | 192.08 | 8.43 | 450.03 |
1995 | 1.94 | 0.55 | 29.39 | 193.84 | 8.43 | 450.86 |
1996 | 1.95 | 0.55 | 29.27 | 194.16 | 8.57 | 451.94 |
1997 | 1.98 | 0.55 | 29.02 | 193.38 | 8.68 | 450.31 |
1998 | 2.01 | 0.56 | 29.48 | 192.18 | 8.86 | 449.61 |
1999 | 2.05 | 0.56 | 29.57 | 191.24 | 9.15 | 451.41 |
2000 | 2.09 | 0.56 | 29.15 | 191.24 | 9.40 | 454.66 |
2001 | 2.13 | 0.54 | 28.31 | 194.45 | 9.66 | 465.81 |
2002 | 2.19 | 0.52 | 27.05 | 201.21 | 10.02 | 488.61 |
2003 | 2.27 | 0.49 | 25.77 | 209.30 | 10.25 | 511.92 |
2004 | 2.34 | 0.47 | 25.13 | 216.51 | 10.55 | 533.42 |
2005 | 2.42 | 0.45 | 24.09 | 220.58 | 10.65 | 542.53 |
2006 | 2.49 | 0.42 | 22.96 | 221.05 | 10.04 | 530.68 |
2007 | 2.58 | 0.39 | 22.06 | 219.67 | 9.65 | 520.24 |
2008 | 2.67 | 0.37 | 21.54 | 217.49 | 9.51 | 512.75 |
2009 | 2.74 | 0.36 | 21.05 | 215.64 | 9.49 | 506.78 |
2010 | 2.78 | 0.34 | 20.46 | 215.17 | 9.54 | 503.47 |
2011 | 2.80 | 0.33 | 19.65 | 216.38 | 9.47 | 500.18 |
2012 | 2.80 | 0.31 | 18.78 | 218.38 | 9.31 | 496.96 |
2013 | 2.80 | 0.29 | 18.23 | 220.47 | 9.24 | 494.70 |
2014 | 2.79 | 0.29 | 17.89 | 222.01 | 9.24 | 493.45 |
2015 | 2.81 | 0.28 | 17.49 | 222.30 | 9.17 | 490.38 |
2016 | 2.84 | 0.27 | 17.39 | 213.38 | 9.25 | 481.78 |
2017 | 2.90 | 0.27 | 17.36 | 204.01 | 9.24 | 470.78 |
2018 | 3.03 | 0.27 | 17.68 | 202.00 | 9.19 | 470.05 |
2019 | 3.26 | 0.27 | 18.24 | 201.06 | 9.17 | 476.52 |
[1] | |
[2] |
《中国心血管健康与疾病报告》编写组. 《中国心血管健康与疾病报告2020》概述[J]. 中国心血管病研究,2021,19(7):582-590. DOI:10.3969/j.issn.1672-5301.2021.07.002.
|
[3] |
丁贤彬,毛德强,焦艳,等. 重庆市糖尿病患病率、死亡率及伤残调整寿命年率分析[J]. 上海交通大学学报(医学版),2021,41(1):78-81. DOI:10.3969/j.issn.1674-8115.2021.01.014.
|
[4] |
陈文婕,钱永刚,初迪,等. 1990—2019年内蒙古自治区糖尿病疾病负担趋势研究[J]. 疾病监测,2022,37(6):826-831. DOI:10.3784/jbjc.202110150546.
|
[5] |
官昊宇,俞浩,罗鹏飞,等. 1990—2019年江苏省居民2型糖尿病疾病负担及其变化趋势分析[J]. 中国慢性病预防与控制,2022,30(9):666-671. DOI:10.16386/j.cjpccd.issn.1004-6194.2022.09.006.
|
[6] |
徐英,李志学,马艳,等. 1990—2019年中国成年人归因于2型糖尿病的癌症疾病负担研究[J]. 中国肿瘤,2022,31(12):959-966.
|
[7] |
GBD Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories,1990—2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1223-1249. DOI:10.1016/S0140-6736(20)30752-2.
|
[8] |
|
[9] |
杨明,汪舒文,宇传华. 1990—2019年中国皮肤恶性肿瘤疾病负担状况及发病趋势预测[J]. 中国肿瘤,2022,31(11):853-861. DOI:10.11735/j.issn.1004-0242.2022.11.A002.
|
[10] |
GBD. Global fertility,mortality,migration,and population forecasts 2017—2100[EB/OL]. [2022-11-15].
|
[11] |
郑荣寿,陈万青. 基于贝叶斯方法的年龄-时期-队列预测模型的介绍[J]. 中华预防医学杂志,2012,46(7):648-650. DOI:10.3760/cma.j.issn.0253-9624.2012.07.016.
|
[12] |
许晴晴,严永富,陈浩,等. 中国四大慢性病死亡率可持续发展目标实现的预测研究[J]. 中华流行病学杂志,2022,43(6):878-884. DOI:10.3760/cma.j.cn112338-20211028-00830.
|
[13] |
International Diabetes Federation. IDF diabetes atlas[EB/OL]. [2022-11-15].
|
[14] |
|
[15] |
黎倩欣,周尚成,陈飘飘,等. 深圳市糖尿病疾病经济负担研究[J]. 卫生经济研究,2021,38(3):63-66. DOI:10.14055/j.cnki.33-1056/f.2021.03.032.
|
[16] |
王俊,王丽丹,江启成,等. 我国糖尿病直接医疗费用研究系统评价[J]. 现代预防医学,2018,45(3):462-466,490.
|
[17] | |
[18] |
彭莉,韩攀. Ⅱ型糖尿病患者的体力活动水平、静坐时间与其糖脂代谢的关系[J]. 现代预防医学,2017,44(23):4391-4394.
|
[19] |
姜莹莹,刘敏,吉宁,等. 1990—2016年中国高BMI导致的糖尿病疾病负担研究[J]. 中华流行病学杂志,2019,40(1):46-51. DOI:10.3760/cma.j.issn.0254-6450.2019.01.010.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
袁晓霞,钟艾霖,周尚成,等. 2017—2019年广州市糖尿病早死概率及疾病负担分析[J]. 现代预防医学,2021,48(5):784-788.
|
[24] |
[1] | ZHANG Yuan, HOU Qiqi, QI Qi, JIANG Yue, WANG Nan, YUE Bocheng, CHEN Shuohua, HAN Quanle, WU Shouling, LI Kangbo. Relationship between Cardiovascular Health Score of Life's Essential 8 and New-onset Atrial Fibrillation: a Large Sample, Long-Term Follow-up Study [J]. Chinese General Practice, 2024, 27(12): 1431-1437. |
[2] | JIN Menglong, QIN Xiaoying, MALIYA Amiti, JIAZINI Nuerbai, LI Jianxin, CAO Jie, LUO Sifu, LIU Cheng, ZHANG Yuchen, GAI Mintao, LI Yanpeng, LU Xiangfeng, FU Zhenyan. Status and Influencing Factors of Dyslipidemia, Hypertension and Diabetes Comorbidities among Kazakhs in Xinjiang [J]. Chinese General Practice, 2024, 27(12): 1438-1444. |
[3] | ZHANG Shengnan, XU Shihua, HUANG Rongchao, CHEN Jian, ZHAO Chunru, MENG Minglyu, MA Yingjiao. Trend and Forecast Analysis of Premature Mortality Probability by Four Major Non-communicable Diseases in Baise from 2015 to 2021 [J]. Chinese General Practice, 2024, 27(11): 1387-1394. |
[4] | LIANG Dong, YANG Chenglin, LIN Xiaoru, ZHAO Yang, OUYANG Jiang, LIN Xiuquan. Burden of Cardiovascular Diseases Attributable to Diabetes among Chinese Adults from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(11): 1380-1386. |
[5] | DAI Zhenwei, ZHANG Ling, ZHANG Haoran, XIAO Weijun, WANG Hao, HUANG Yiman, JING Shu, CHEN Xu, FU Jiaqi, WU Yijin, GAO Lei, SU Xiaoyou. Influencing Factors of Blood Glucose Monitoring in Middle-aged and Elderly Patients with Type-2 Diabetes Mellitus in Rural Areas [J]. Chinese General Practice, 2024, 27(10): 1194-1200. |
[6] | CHEN Dan, WANG Yawei, HUANG Fang, XU Yifan, ZHANG Yiying, SHAO Yueqin. Epidemic Trend Analysis of Colorectal Cancer in Jiading District, Shanghai from 2003 to 2019 [J]. Chinese General Practice, 2024, 27(10): 1261-1266. |
[7] | HAN Junjie, WU Di, CHEN Zhisheng, XIAO Yang, SEN Gan. A Nomogram Prediction Model and Validation Study on the Risk of Complicated Diabetic Nephropathy in Type 2 Diabetes Patients [J]. Chinese General Practice, 2024, 27(09): 1054-1061. |
[8] | WANG Xueting, JIANG Yi. Disease Burden of Chronic Obstructive Pulmonary Disease in the BRICS Countries from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(09): 1118-1125. |
[9] | HE Yufu, TONG Wenying, WANG Fang, LI Lixia, HE Junbing, SHAO Yiming. Effects of Pre-hospital Metformin Use on Clinical Outcomes in Patients with Diabetes and Sepsis [J]. Chinese General Practice, 2024, 27(09): 1034-1041. |
[10] | LI Ziyue, FANG Jiawen, LIN Kaicheng. Analysis and Prediction of the Disease Burden of Type 2 Diabetes Attributable to High Body Mass Index in China from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(09): 1126-1133. |
[11] | GAO Yuan, ZHOU Min, QIN Manfen, XU Xuan, YANG Liping, FU Yahong, HUANG Ying, WANG Wei. Effects of Health Coaching Combined with Wearable Devices on Glucose and Lipid Metabolism and Self-management Behavior in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2024, 27(08): 908-914. |
[12] | ZOU Qiong, WU Xi, ZHANG Yang, WAN Yi, CHEN Changsheng. Prediction of Type 2 Diabetic Nephropathy Based on BP Neural Network Optimized by Sparrow Search Algorithm [J]. Chinese General Practice, 2024, 27(08): 961-970. |
[13] | YAO Mi, LIN Kai, FAN Jieting, JI Xinxin, WANG Ying, DONG Aimei, HAN Xiaoning, QI Jianguang, CHI Chunhua, Haroon Shamil, Jackson Dawn, Cheng KK, Lehman Richard. Design and Development of Communication Skills Training in Diabetes Care for General Practitioners in China [J]. Chinese General Practice, 2024, 27(07): 816-821. |
[14] | YUAN Xianxian, LI Jing, WANG Jia, ZHANG Kexin, YANG Ruihua, ZHENG Wei, LI Guanghui. Prevalence of Dyslipidemia in Pregnancy and Early Predictive Value of Blood Lipid Levels [J]. Chinese General Practice, 2024, 27(06): 670-678. |
[15] | ZENG Senxiang, YANG Rui, DENG Xun, YANG Ruitao, YANG Xiaoyan. Management Standards of Polypharmacy in Type 2 Diabetes Combined with Atherosclerotic Cardiovascular Diseases in the Elderly [J]. Chinese General Practice, 2024, 27(05): 597-603. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||